The start-up companies which have been selected to join the third Oxford AHSN Accelerator programme Oct-Dec 2021 are – find out more about them below:
- Bedqueue: Accurately predicting a patient’s length of stay in hospital to enable proactive discharge planning
- Celera Dynamics: Developing an analytic system combining optical sensors and data analysis to determine protein production in biotechnological processes
- Gate2Brain: Improving drug delivery across biological barriers such as blood-brain
- Oxomics: Developing a minimally invasive, single-shot platform technology for disease diagnosis and prognosis
- RCube Health: Providing personalised care for anxiety through a digital treatment app called Resony
- Neobe Therapeutics: Improving immunotherapeutic efficacy in oncology by engineering live biotherapeutic products to locally disrupt the tumour microenvironment